USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/16668
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTverdohleb, Cristina-
dc.date.accessioned2021-04-13T11:09:05Z-
dc.date.available2021-04-13T11:09:05Z-
dc.date.issued2017-
dc.identifier.citationTVERDOHLEB, Cristina. Particularităţile farmacovigilenţei în Republica Moldova = The particularities of pharmacovigilance in Republic of Moldova. In: Revista Farmaceutică a Moldovei. 2017, nr. 1-2, p. 105. ISSN 1812-5077.en_US
dc.identifier.issn1812-5077-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/16668-
dc.descriptionUniversitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldovaen_US
dc.description.abstractIntroducere. Pentru a preveni şi diminua riscul apariţiei reacţiilor adverse (RA) la medicamente se impune necesitatea unui sistem de farmacovigilenţă bine organizat, acesta constituind un element cheie al practicii medicale şi farmaceutice [1]. Scopul lucrării. Evaluarea monitorizării reacţiilor adverse în cadrul activităţii de farmacovigilenţă a R. Moldova în anul 2016. Material şi metode. Au fost cercetate şi evaluate fişele- comunicare ale reacţiilor adverse recepţionate de către Secţia farmacovigilenţă a Agenţiei Medicamentului. Rezultate. în 2016 au fost recepţionate 277 fişe- comunicare a reacţiilor adverse, dintre care 12 cazuri de ineficienţă a preparatului medicamentos. Majoritatea bolnavilor au manifestat reacţii alergice la preparatele antituberculoase, cu o pondere de 33% şi medicamentele predestinate tratamentului infecţiei HIV-SIDA, cu 13%. Cel mai frecvent raportate au fost cazurile de RA la: antituberculoase - 116, antibiotice - 30, substanţe de contrast - 15, antihipertensive - 7, soluţii perfuzabile - 27, antiretrovirale - 11. Majoritatea RA raportate au fost apreciate, ca fiind de gravitate medie (67,55%), iar cele grave constituind -17,21%, fapt ce reflectă că mai mult de jumătate din RA comportă im caracter periculos pentru starea sănătăţii pacientului. Concluzii. Majoritatea bolnavilor au manifestat RA la preparatele antituberculoase şi retrovirale. Reacţiile adverse raportate au fost apreciate, ca fiind de gravitate medie şi grave.en_US
dc.description.abstractIntroduction. For the prevention and reduction of the risk of appearance of adverse reactions (AR) of drugs, the necessity of the well organized system of pharmacovigilance is imposed, that constitutes one of the most important elements of the medical and pharmaceutical practice [1]. The aim of the study. The evaluation of the surveillance system for adverse reactions in the activity of pharmacovigilance of R. Moldova in 2016. Material and methods. The investigation and evaluation of communication files of the adverse reactions collected by the Section of pharmacovigilance of the Drug Agency. Results. In 2016, 277 communication files of adverse reactions were collected, including 12 cases of inefficiency of drugs. Most patients showed the allergic reactions to antituberculosis drugs, with the rate of 33% and drugs predestinated to treatment of HIV-SIDA infection with 13%. The most frequent cases of AR were: antituberculosis-116, antibiotics-30, substances of contrast-15, antihypertensive-7, infusion solutions-27, antiretroviral-11. Most of the cases of AR was appreciated with medium gravity (67,55%) and the severe cases (17,21%), this reflected that more than half of AR cases had a dangerous character for the health of the patient. Conclusions. Most of patients manifested AR for antituberculosis and retroviral drugs. Reported adverse reactions were appreciated with a medium and advanced severity.en_US
dc.publisherAsociația Farmaciștilor din Republica Moldovaen_US
dc.relation.ispartofRevista Farmaceutică a Moldovei: Materials of First Congress of Pharmaceutical Students Association from Republic of Moldova dedicated to the Year Nicolae Testemitanu "Innovation and creativity in pharmaceutical practice and research”, May 4-7, 2017, Chisinau, Republic of Moldovaen_US
dc.subjectpharmacovigilanceen_US
dc.subjectadverse reactionsen_US
dc.subjectdrugsen_US
dc.subjectcommunication-filesen_US
dc.titleParticularităţile farmacovigilenţei în Republica Moldovaen_US
dc.title.alternativeThe particularities of pharmacovigilance in Republic of Moldovaen_US
dc.typeOtheren_US
Appears in Collections:Revista Farmaceutică a Moldovei Nr. 1-2, 2017

Files in This Item:
File Description SizeFormat 
Tverdohleb_Cristina_Particularitatile_farmacovigilentei_in_Republica_Moldova_p.105.pdf1.2 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback